Comprehensive Cancer Center Erlangen
In research, Comprehensive Cancer Center Erlangen stands highest in Medicine (#1,622 of 10,443 worldwide), Health Sciences (#2,375 of 11,982 worldwide) and Life Sciences (#3,168 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 11.8× its share of world research.
- World rank, 2022–2025
- #5,393 of 28,054 · #10,591 all time
- Rank in Germany
- #230 of 1,178
- Research works
- 566 ▲ 146% vs 2013–17
- Citations
- 11k 19.0 per fractional work
- Top-10% rate
- 26.2% record average 16.5%
- Open access
- 66% world 28%
What is Comprehensive Cancer Center Erlangen known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,622 of 10,443 | 25.3% | 176 | #3886 | |
| Health SciencesDomain | #2,375 of 11,982 | 25.6% | 186 | #5187 | |
| Life SciencesDomain | #3,168 of 7,800 | 25.2% | 64 | #5525 |
Each strip is that field’s whole ranked pool, with the notch where Comprehensive Cancer Center Erlangen sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#3,886 #1,622
- Health Sciences#5,187 #2,375
- Life Sciences#5,525 #3,168
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Comprehensive Cancer Center Erlangen specialise in?
Where its research is concentrated relative to its size: Oncology takes 11.8× the share of its output that it takes of world research.
- OncologySubfield · 36.9 works12×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.8×. Every wedge is a field page.
- Immunology and Microbiology 5.8×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 2.8×
- Dentistry 2.1×
- Neuroscience 1.2×
- Physics and Astronomy 1.1×
- Nursing 1.0×
- Veterinary 0.9×
- Health Professions 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Psychology 0.3×
- Computer Science 0.2×
- Economics, Econometrics and Finance 0.2×
- Chemistry 0.2×
- Decision Sciences 0.2×
- Engineering 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Arts and Humanities 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Environmental Science 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Comprehensive Cancer Center Erlangen?
Ranked on the composite score, Paul Gaß and Erik Belleville lead among researchers whose main affiliation is Comprehensive Cancer Center Erlangen.
- 1 Paul Gaß Germany · #957,451 worldwide 24 citations · 23 works
- 2 Erik Belleville Germany · #1,499,426 worldwide 16 citations · 17 works
Which keywords describe research at Comprehensive Cancer Center Erlangen?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Radiotherapy, Clinical Practice Guidelines, Survival Analysis, Neoadjuvant Therapy, Tumor Microenvironment and Prognostic Factors.
- Treatment Response
- Cervical Cancer
- Targeted Therapy
- Genomic Instability
- Molecular Classification
- Monte Carlo Simulation
- Sentinel Lymph Node Biopsy
- PD-1 and PD-L1
- Prognostic Markers
- Dosimetry
- Radiation Therapy
- Cancer Immunotherapy
- Squamous Cell Carcinoma
- Gene Expression
- Metastasis
- Tumor Microenvironment
- Survival Analysis
- Clinical Practice Guidelines
- Epidemiology
- Immunotherapy
- Chemotherapy
- Radiotherapy
- Cancer
- Inflammation
- Neoadjuvant Therapy
- Prognostic Factors
- Quality of Life
- Breast Cancer
- Immunity
- Molecular Characterization
- Genetic Mutations
- Human Papillomavirus
- Immune Checkpoint Blockade
- Precision Medicine
- Clinical Guidelines
- Image-Guided Radiotherapy
- Radiotherapy Physics
- Molecular Subtypes
- Survival
- Breast Tumours
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy21▲ 11×22 topics
- Immunotherapy20▲ 10×17 topics
- Radiotherapy19▲ 18×11 topics
- Epidemiology19▲ 1.72×65 topics
- Cancer15▲ 4.1×36 topics
- Clinical Practice Guidelines15▲ 9.7×12 topics
- Inflammation14▲ 2.5×60 topics
- Survival Analysis14▲ 18×6 topics
- Neoadjuvant Therapy13▲ 20×5 topics
- Tumor Microenvironment12▲ 10×8 topics
- Prognostic Factors12▲ 9.9×14 topics
- Metastasis10▲ 11×10 topics
- Quality of Life10▲ 2.6×25 topics
- Gene Expression10▲ 6.0×12 topics
- Breast Cancer10▲ 15×11 topics
- Squamous Cell Carcinoma9▲ 35×3 topics
- Immunity8▲ 7.5×8 topics
- Cancer Immunotherapy8▲ 19×3 topics
- Molecular Characterization8▲ 16×4 topics
- Radiation Therapy8▲ 21×4 topics
- Genetic Mutations7▲ 6.2×16 topics
- Dosimetry7▲ 37×2 topics
- Human Papillomavirus7▲ 21×3 topics
- Prognostic Markers7▲ 24×3 topics
- Immune Checkpoint Blockade7▲ 23×1 topic
- PD-1 and PD-L17▲ 23×1 topic
- Precision Medicine7▲ 5.4×7 topics
- Sentinel Lymph Node Biopsy7▲ 30×2 topics
- Clinical Guidelines7▲ 8.4×7 topics
- Monte Carlo Simulation7▲ 12×2 topics
- Image-Guided Radiotherapy6▲ 55×1 topic
- Molecular Classification6▲ 15×3 topics
- Radiotherapy Physics6▲ 55×1 topic
- Genomic Instability6▲ 21×3 topics
- Molecular Subtypes6▲ 27×3 topics
- Targeted Therapy6▲ 9.9×5 topics
- Survival6▲ 16×4 topics
- Cervical Cancer6▲ 20×3 topics
- Breast Tumours6▲ 44×1 topic
- Treatment Response6▲ 44×1 topic
Which research topics does Comprehensive Cancer Center Erlangen publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Advanced Radiotherapy Techniques, Breast Cancer Treatment Studies and Head and Neck Cancer Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 7 works
- 2 Advanced Radiotherapy Techniques Radiation 6 works
- 3 Breast Cancer Treatment Studies Cancer Research 6 works
- 4 Head and Neck Cancer Studies Otorhinolaryngology 5 works
- 5 Immunotherapy and Immune Responses Immunology 4 works
- 6 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
- 7 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 4 works
- 8 Bladder and Urothelial Cancer Treatments Surgery 4 works
- 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
- 10 Nonmelanoma Skin Cancer Studies Epidemiology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Comprehensive Cancer Center Erlangen's research output changed?
Output in 2018–2022 was 146% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Erlangen
- Friedrich-Alexander-Universität Erlangen-Nürnberg
- Universitätsklinikum Erlangen
- Fraunhofer Institute for Integrated Circuits
- Max Planck Institute for the Science of Light
- Fraunhofer Institute for Integrated Systems and Device Technology
- Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit
- Framatome (Germany)
- Helmholtz Institute Erlangen-Nürnberg
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.